JGJinn‐Yuh Guh

Jinn‐Yuh Guh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jinn‐Yuh Guh has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Hung‐Chun Chen

    Department of Nephrology, Kaohsiung Medical University, Kaohsiung, Taiwan

    3 shared publications
  • Lea‐Yea Chuang

    Department of Biochemistry, Kaohsiung Medical University, Kaohsiung, Taiwan

    3 shared publications
  • Wen‐Chun Hung

    Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan

    3 shared publications
  • Chu‐I Lee

    Department of Medical Technology, Fooyin University, Kaohsiung, Taiwan

    2 shared publications
  • Hung-Chun Chen

    Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

    2 shared publications
  • Lea-Yea Chuang

    Department of Biochemistry, Kaohsiung Medical University, 100 Shi-Chuan 1st Road, Kaohsiung 807, Taiwan

    2 shared publications

Latest Publications

  • High glucose decreases endothelial cell proliferation via the extracellular signal regulated kinase/p15INK4b pathway

    by Yen-Hui Chen, Jinn-Yuh Guh, Tsai-Der Chuang, Hung-Chun Chen, Shean-Jaw Chiou, Jau-Shyang Huang, Yu-Lin Yang, Lea-Yea Chuang


  • Sp1 and Smad3 are required for high glucose‐induced p21WAF1 gene transcription in LLC‐PK1 cells

    by Tsai‐Der Chuang, Jinn‐Yuh Guh, Shean‐Jaw Chiou, Hung‐Chun Chen, Wen‐Chun Hung, Lea‐Yea Chuang

    The cyclin‐dependent kinase inhibitor p21WAF1 is required for diabetic glomerular hypertrophy. High glucose‐induced hypertrophy in proximal tubule cells is dependent on transforming growth factor‐β (TGF‐β). Many of the TGF‐β‐induced effects are dependent on Smad2/3. Thus, the molecular mechanisms of high glucose‐induced p21WAF1 and hypertrophy were studied in high glucose‐cultured proximal tubule‐like LLC‐PK1 cells. We found that high glucose (30 mM) induced hypertrophy at 72 h. High glucose also increased the expression of p21WAF1 protein and p21WAF1 mRNA transcription and abundance at 48 h. The DNA element in the 5′ regulatory region of p21WAF1 gene essential for high glucose‐induced p21WAF1 gene transcription was identified as Sp1 by a series of the 5′ regulatory region of p21WAF1 gene deletion mutants. Moreover, high glucose activated Smad2/3 while increasing the Sp1 DNA‐binding activity. High glucose also increased the Sp1‐dependent transcriptional activity of p21WAF1 gene. High glucose‐induced hypertrophy was attenuated by p21WAF1 short interfering RNA and Smad3 dominant‐negative plasmid transfection. We concluded that high glucose induced hypertrophy via Sp1‐Smad2/3‐dependent activation of p21WAF1 gene transcription in LLC‐PK1 cells. J. Cell. Biochem. 102: 1190–1201, 2007.


  • Open Access

    Betel-quid use is associated with heart disease in women

    by Jinn-Yuh Guh, Hung-Chun Chen, Jung-Fa Tsai, Lea-Yea Chuang

    Background: Betel quid (Areca catechu) is used by ≈10% of the world population. Betel-quid use is associated with the metabolic syndrome—a risk factor for heart disease. Objective: The objective was to test whether betel-quid use is associated with heart disease in adults. Design: Nonpregnant adults aged 20–64 y (n = 1932, 52% women) from the nationally representative Nutrition and Health Survey in Taiwan (1993–1996) were studied for independent associations between betel-quid use and heart disease after adjustment for lifestyle factors, age, obesity, diabetes mellitus, hypertension, and concentrations of serum total cholesterol and HDL cholesterol. Results: The prevalence of betel-quid use was higher in men than in women (31% compared with 2.4%; P < 0.001). The prevalence of heart disease was not significantly different between men and women (3.3% compared with 2.3%; P = 0.12). The prevalence of betel-quid use decreased, whereas the prevalence of heart disease increased, with age. Betel-quid users were younger, drank more, had a lower dietary fruit intake, had a higher Framingham risk score, and had higher serum triacylglycerol concentrations than did the nonusers. At a mean consumption rate of 10 times/d (the third quartile of betel-quid consumption in betel-quid users), betel-quid use was independently associated with the Framingham risk score in subjects without heart disease only if obesity was not included as an adjustment factor (P = 0.007). Moreover, the daily rate of betel-quid use was independently associated with prevalent heart disease; the odds ratio associated with a betel-quid consumption rate of 10 times/d was 1.37 (95% CI: 1.1, 1.6; P = 0.003) in women. Conclusion: Betel-quid use is independently associated with heart disease in women.


  • Advanced glycation end‐product‐induced mitogenesis and collagen production are dependent on angiotensin II and connective tissue growth factor in NRK‐49F cells

    by Chu‐I Lee, Jinn‐Yuh Guh, Hung‐Chun Chen, Wen‐Chun Hung, Yu‐Lin Yang, Lea‐Yea Chuang

    Diabetic nephropathy (DN) is characterized by glomerulopathy and tubulointerstitial expansion followed by renal fibrosis. Angiotensin II (Ang II) and connective tissue growth factor (CTGF) are involved in the pathogenesis of DN, while Janus kinase 2 (JAK2) is important in advanced glycation end‐product (AGE)‐induced effects in renal interstitial (NRK‐49F) fibroblasts. Thus, we studied the role of Ang II, CTGF, and JAK2 in AGE‐induced effects in NRK‐49F cells. We found that AGE (150 μg/ml) increased mitogenesis and type I collagen production at 7 days while Ang II (10−7M) increased mitogenesis and type I collagen production at 3 days. We also found that AGE (150 μg/ml) increased angiotensinogen protein at 2 days, which was attenuated by AG‐490 (a JAK2 inhibitor). AGE (150 μg/ml) increased CTGF mRNA and protein expression at 3 and 5 days, respectively. Ang II (10−7M) increased CTGF mRNA and protein expression at 1 and 2 days, respectively, which were attenuated by AG‐490. Moreover, losartan (a type I angiotensin receptor blocker) and captopril (an angiotensin converting enzyme inhibitor) attenuated AGE‐induced CTGF mRNA/protein expression while attenuating AGE‐induced mitogenesis and type I collagen production. AG‐490 and CTGF antisense (but not sense) oligodeoxynucleotide (ODN) attenuated Ang II (10−7M) and AGE‐induced mitogenesis and type I collagen production at 3 and 7 days, respectively. We concluded that AGE (150 μg/ml)‐induced mitogenesis and type I collagen production are dependent on the Ang II‐JAK2‐CTGF pathway in NRK‐49F cells. Moreover, Ang II‐induced mitogenesis and type I collagen production are dependent on the JAK2‐CTGF pathway.


  • Leptin and connective tissue growth factor in advanced glycation end‐product‐induced effects in NRK‐49F cells

    by Chu‐I Lee, Jinn‐Yuh Guh, Hung‐Chun Chen, Kuan‐Hua Lin, Yu‐Lin Yang, Wen‐Chun Hung, Yung‐Hsiung Lai, Lea‐Yea Chuang

    Previously, we showed that Janus kinase 2 (JAK2) is important in advanced glycation end‐product (AGE)‐induced effects in renal interstitial (NRK‐49F) fibroblasts. Leptin is a JAK2‐activating cytokine via the long form leptin receptor (Ob‐Rb). Leptin and connective tissue growth factor (CTGF) may be involved in renal fibrosis. However, the relationship between leptin and CTGF in terms of AGE‐induced effects remains unknown. Thus, the effects of AGE (150 μg/ml) and leptin on mitogenesis, CTGF and collagen expression in NRK‐49F cells were determined. We found that leptin and AGE increased mitogenesis and type I collagen protein expression at 3 and 7 days, respectively. AGE increased leptin mRNA and protein expression at 2–3 days. AGE increased CTGF mRNA and protein expression at 3–5 days. AG‐490 (JAK2 inhibitor) abrogated AGE‐induced leptin mRNA and protein expression at 2–3 days. AG‐490 and Ob‐Rb anti‐sense oligodeoxynucleotides (ODN) abrogated AGE‐induced CTGF mRNA and protein expression at 3–5 days. AG‐490 and CTGF anti‐sense ODN abrogated AGE‐induced mitogenesis and collagen protein expression at 7 days. Additionally, leptin dose (0.2–1 μg/ml) and time (1–2 days)‐dependently increased CTGF protein expression. AG‐490 abrogated leptin (1 μg/ml)‐induced CTGF protein expression at 2 days. AG‐490 and CTGF anti‐sense ODN abrogated leptin‐induced mitogenesis and collagen protein expression at 3 days. We concluded that AGE induced JAK2 to increase leptin while leptin induced JAK2 to increase CTGF‐induced mitogenesis and type I collagen protein expression in NRK‐49F cells. Additionally, AGE‐induced mitogenesis and type I collagen protein expression were dependent on leptin‐induced CTGF.